Sanofi Strikes Deal With Mysterious Psychedelics Biotech Terran
New York-based Terran Biosciences inked a deal with Paris-based Sanofi for two late-stage central nervous system (CNS) assets. Terran plans to advance them for neurological and psychological indications.
Source: biospace.com